Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 50
  • Start Date: September 2020
Multicentre, Randomized, Prospective Trial Evaluating the Efficacy and Safety of Infliximab to Tocilizumab in Refractory or Relapsing Takayasu Arteritis
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 130
  • Start Date: March 1, 2020
Randomized Open-label Study in Mild and Moderate Patients With Takayasu Arteritis Between Methotrexate and Tofacitinib Based on the ECTA Cohort.
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Biological
  • Participants: 40
  • Start Date: March 1, 2020
A Pilot Study in the Treatment of Severe Patients With Takayasu Arteritis With Tocilizumab and Adalimumab, Based on ECTA Cohort
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Diagnostic Test
  • Participants: 20
  • Start Date: January 8, 2020
Takayasu Arteritis Activity Evaluation by Ultrafast Ultrasound Imaging
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Device
  • Participants: 90
  • Start Date: October 1, 2019
Comparison of Drug-eluting Balloon and Plain Balloon for Treatment of Non-atherosclerotic Renal Artery Stenosis: a Randomized Controlled Study
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Diagnostic Test
  • Participants: 25
  • Start Date: June 25, 2019
The PET Imaging of Giant Cell and Takayasu Arteritis Study
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 44
  • Start Date: October 1, 2018
Aerobic Capacity and Strength Exercise in Takayasu's Arteritis: Impact on Clinical, Laboratory and Vascular Parameters
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 150
  • Start Date: June 20, 2018
Observational Multicenter Study of Refractory and/or Relapsing Takayasu Arteritis START: Study of Refractory and/or Relapsing TAkayasu aRTeritis
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2/Phase 3
  • Intervention Type: Drug
  • Participants: 40
  • Start Date: June 1, 2018
Does Inactive Takayasu Arteritis(NIH Criteria) Need Anti-inflammatory Treatment?
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Biological, Drug
  • Participants: 1000
  • Start Date: November 1, 2016
The Cohort Study of East Chinese Takayasu's Arteritis (ECTA-cohort Study)
Showing 1-12 of 18